Transformation Atlas
Research-Based Intelligence
Daily Report

Opportunity Finder — Daily Report

As of 2026-07-14 · 78 opportunities flagged (top-tier business quality, elevated market doubt).

News overlay · as of 2026-07-12, carried from the last weekly run (recomputes weekly)

Top 10 — quality × doubt

#CompanySectorQual %ileDoubtRecommended next step
1ZTS
Zoetis Inc.
Healthcare92.8%1.00BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT INSIDERS BUYING Signals: cheap vs history · off highs · below trend · near low
2ADBE
Adobe Inc.
Technology97.4%0.95HOLD OFF — CONFIRM THE TURN
DEBATED Signals: cheap vs history · off highs · below trend · near low · turning up
3LULU
Lululemon Athletica Inc.
Consumer Cyclical87.2%0.96BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT INSIDER BUYING Signals: cheap vs history · off highs · below trend · near low
4CPRT
Copart, Inc.
Industrials90.8%0.94BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low
5ADSK
Autodesk, Inc.
Technology87.4%0.83BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT INSIDERS BUYING Signals: cheap vs history · off highs · below trend · near low
6IT
Gartner, Inc.
Industrials84.4%0.98BUY CANDIDATE — WORTH A CLOSE LOOK
DEBATED Signals: cheap vs history · off highs · below trend · near low
7RMD
ResMed Inc.
Healthcare97.2%0.82BUY CANDIDATE — WORTH A CLOSE LOOK
NEWS CONSTRUCTIVE Signals: cheap vs history · off highs · below trend · near low
8IDXX
IDEXX Laboratories, Inc.
Healthcare98.2%0.69HOLD OFF — CONFIRM THE TURN
NEWS CONSTRUCTIVE Signals: cheap vs history · off highs · below trend · turning up
9INTU
Intuit Inc.
Technology78.8%0.99RESEARCH THE CAUSE FIRST
DEBATED Signals: cheap vs history · off highs · below trend · near low
10TTD
The Trade Desk, Inc.
Communication Services91.4%0.99RECONSIDER — DOUBT MAY BE EARNED
DOUBT EARNED Signals: cheap vs history · off highs · below trend · near low
⇩ Full report (PDF) ⇩ Ranked CSV ⇩ Data (JSON) How these are ranked
Per-name detail

The 10 companies, in depth

1. ZTS Zoetis Inc.

DOUBT = SENTIMENT

Drug Manufacturers - General · adj close 73.52 (div-adj)

Quality 92.8% pctile
Market doubt 1.00 / 1.00

News read — the doubt looks like sentiment, not damage: No hard negatives, earnings beats, or structural questions. Pure valuation pullback with institutional buying support.. Lifts the opportunity score to 1.00 (from 0.92).

Business quality fingerprint

Returns
ROIC21.5%
ROE80.2%
Gross profitability43.1%
Margins
Gross margin70.5%
Operating margin38.0%
FCF margin24.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.4%
EPS CAGR10.3%
Balance sheet
Net debt / EBITDA1.76
Share count (5-yr)-6.9%
Quality score0.81 · 92.8% pctile

What it does

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.

Doubt & mispricing

The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 53% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -52.5% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

2. ADBE Adobe Inc.

DEBATED

Software - Application · adj close 230.61 (div-adj)

Quality 97.4% pctile
Market doubt 0.95 / 1.00

News read — a real but unresolved debate — no clear damage yet: Real but unresolved AI disruption concern vs. strong fundamentals; no realized earnings miss or guidance cut.. Leaves the opportunity score about unchanged.

Business quality fingerprint

Returns
ROIC36.7%
ROE61.3%
Gross profitability71.4%
Margins
Gross margin88.6%
Operating margin36.6%
FCF margin41.4% (FCF+)
Growth (3-yr)
Revenue CAGR10.5%
EPS CAGR18.2%
Balance sheet
Net debt / EBITDA0.12
Share count (5-yr)-11.2%
Quality score0.88 · 97.4% pctile

What it does

Adobe Inc. stands as a prominent global software provider, delivering a diverse range of solutions. Its operations are structured into three primary business divisions: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment empowers individuals, teams, and enterprises to generate, disseminate, and amplify various forms of content through its array of products and services, including the cloud-native Document Cloud platform.

Doubt & mispricing

The market doubts it (score 0.95): trading cheap versus its own multi-year range; down 38% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

3. LULU Lululemon Athletica Inc.

DOUBT = SENTIMENT

Apparel - Retail · adj close 119.58 (div-adj)

Quality 87.2% pctile
Market doubt 0.96 / 1.00

News read — the doubt looks like sentiment, not damage: Pure valuation pullback with no fundamental damage. Recent news shows price recovery, strong fundamentals, and institutional buying.. Lifts the opportunity score to 0.93 (from 0.85).

Business quality fingerprint

Returns
ROIC22.7%
ROE31.8%
Gross profitability74.3%
Margins
Gross margin56.6%
Operating margin19.9%
FCF margin8.3% (FCF+)
Growth (3-yr)
Revenue CAGR11.0%
EPS CAGR25.7%
Balance sheet
Net debt / EBITDA-0.00
Share count (5-yr)-8.6%
Quality score0.76 · 87.2% pctile

What it does

Lululemon Athletica Inc., alongside its subsidiaries, specializes in the design, global distribution, and retail of athletic apparel and accessories for both women and men. Its business operations are structured into two main divisions: company-owned retail establishments and direct-to-consumer sales. The firm's offerings encompass a range of clothing such as pants, shorts, tops, and jackets, all crafted for promoting a healthy lifestyle and facilitating athletic endeavors. These activities span yoga, running, training, and other physically demanding pursuits.

Doubt & mispricing

The market doubts it (score 0.96): trading cheap versus its own multi-year range; down 49% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -48.7% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

4. CPRT Copart, Inc.

DOUBT = SENTIMENT

Specialty Business Services · adj close 27.45 (div-adj)

Quality 90.8% pctile
Market doubt 0.94 / 1.00

News read — the doubt looks like sentiment, not damage: Price decline amid AI-sector rotation; no fundamental damage, earnings miss, guidance cut, or hard negatives reported.. Lifts the opportunity score to 0.90 (from 0.86).

Business quality fingerprint

Returns
ROIC14.7%
ROE16.9%
Gross profitability20.8%
Margins
Gross margin45.2%
Operating margin36.5%
FCF margin26.5% (FCF+)
Growth (3-yr)
Revenue CAGR9.9%
EPS CAGR12.1%
Balance sheet
Net debt / EBITDA-1.27
Share count (5-yr)+1.7%
Quality score0.79 · 90.8% pctile

What it does

Copart, Inc. stands as a prominent global provider of online vehicle auctions and comprehensive vehicle remarketing services. The company extends its operations across numerous international markets, including the United States, the United Kingdom, Germany, Brazil, Canada, the United Arab Emirates, Spain, Finland, Oman, the Republic of Ireland, and Bahrain. At its core, Copart enables the buying and selling of vehicles over the internet through its sophisticated "virtual bidding" online auction platform.

Doubt & mispricing

The market doubts it (score 0.94): trading cheap versus its own multi-year range; down 45% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -45.1% (skim recent headlines + the last earnings call).

Notable: the balance sheet holds net cash, which de-risks the wait.

Recent news

5. ADSK Autodesk, Inc.

DOUBT = SENTIMENT

Software - Application · adj close 212.22 (div-adj)

Quality 87.4% pctile
Market doubt 0.83 / 1.00

News read — the doubt looks like sentiment, not damage: Analyst upgrades and moderate buy ratings; no hard negatives, guidance provided normally.. Lifts the opportunity score to 0.87 (from 0.74).

Business quality fingerprint

Returns
ROIC18.7%
ROE36.9%
Gross profitability52.6%
Margins
Gross margin91.0%
Operating margin24.9%
FCF margin33.4% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR11.4%
Balance sheet
Net debt / EBITDA0.27
Share count (5-yr)-3.2%
Quality score0.76 · 87.4% pctile

What it does

Autodesk, Inc. delivers advanced software and services for 3D design, engineering, and entertainment to a global clientele. Their diverse product line includes AutoCAD Civil 3D, a comprehensive solution for civil engineering tasks such as land development, transportation infrastructure, and environmental projects. For construction project management, they offer BIM 360, a cloud-based platform.

Doubt & mispricing

The market doubts it (score 0.83): trading cheap versus its own multi-year range; down 35% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -35.1% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

6. IT Gartner, Inc.

DEBATED

Consulting Services · adj close 137.07 (div-adj)

Quality 84.4% pctile
Market doubt 0.98 / 1.00

News read — a real but unresolved debate — no clear damage yet: Analyst price-target cut amid unresolved AI disruption debate; no earnings miss or guidance cut.. Leaves the opportunity score about unchanged.

Business quality fingerprint

Returns
ROIC18.8%
ROE227.9%
Gross profitability54.4%
Margins
Gross margin67.7%
Operating margin15.8%
FCF margin18.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.9%
EPS CAGR-1.0%
Balance sheet
Net debt / EBITDA1.54
Share count (5-yr)-16.3%
Quality score0.73 · 84.4% pctile

What it does

Gartner, Inc. functions as a premier research and advisory enterprise, extending its reach across the United States, Canada, Europe, the Middle East, Africa, and various international markets. Its operations are structured into three main divisions: Research, Conferences, and Consulting. The Research division primarily offers a subscription service, enabling on-demand access to extensive published studies, data, industry benchmarks, and direct consultations with its expert network.

Doubt & mispricing

The market doubts it (score 0.98): trading cheap versus its own multi-year range; down 63% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -63.4% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

7. RMD ResMed Inc.

NEWS CONSTRUCTIVE

Medical - Devices · adj close 192.27 (div-adj)

Quality 97.2% pctile
Market doubt 0.82 / 1.00

News read — the news is constructive: Q4 earnings beat expected with double-digit growth; MatrixCare divestiture ($490M) + Noctrix acquisition signal strategic execution.. Lifts the opportunity score to 0.83 (from 0.74).

Business quality fingerprint

Returns
ROIC19.6%
ROE23.5%
Gross profitability37.4%
Margins
Gross margin59.4%
Operating margin32.7%
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR21.5%
Balance sheet
Net debt / EBITDA-0.19
Share count (5-yr)+0.6%
Quality score0.88 · 97.2% pctile

What it does

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices.

Doubt & mispricing

The market doubts it (score 0.82): trading cheap versus its own multi-year range; down 34% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -34.0% (skim recent headlines + the last earnings call).

Notable: the balance sheet holds net cash, which de-risks the wait.

Recent news

8. IDXX IDEXX Laboratories, Inc.

NEWS CONSTRUCTIVE

Medical - Diagnostics & Research · adj close 567.99 (div-adj)

Quality 98.2% pctile
Market doubt 0.69 / 1.00

News read — the news is constructive: Company raised FY2026 earnings guidance; analyst maintains $876 target (27% upside). No hard negatives.. Lifts the opportunity score to 0.83 (from 0.74).

Business quality fingerprint

Returns
ROIC40.3%
ROE66.0%
Gross profitability79.4%
Margins
Gross margin61.8%
Operating margin31.6%
FCF margin24.5% (FCF+)
Growth (3-yr)
Revenue CAGR8.5%
EPS CAGR17.7%
Balance sheet
Net debt / EBITDA0.61
Share count (5-yr)-6.8%
Quality score0.89 · 98.2% pctile

What it does

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments.

Doubt & mispricing

The market doubts it (score 0.69): trading cheap versus its own multi-year range; down 26% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

9. INTU Intuit Inc.

DEBATED

Software - Application · adj close 273.62 (div-adj)

Quality 78.8% pctile
Market doubt 0.99 / 1.00

News read — a real but unresolved debate — no clear damage yet: Job cuts and TurboTax disruption concerns are real secular questions, not realized earnings misses or guidance cuts.. Leaves the opportunity score about unchanged.

Business quality fingerprint

Returns
ROIC14.8%
ROE19.6%
Gross profitability41.1%
Margins
Gross margin80.8%
Operating margin26.1%
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR14.0%
EPS CAGR23.4%
Balance sheet
Net debt / EBITDA0.64
Share count (5-yr)+3.7%
Quality score0.69 · 78.8% pctile

What it does

Intuit Inc. delivers a comprehensive array of financial management and regulatory compliance solutions, serving individual consumers, small businesses, independent contractors, and accounting professionals across the United States, Canada, and various international markets. The company's operations are structured into four primary divisions: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment offers the popular QuickBooks ecosystem, which includes cloud-based solutions like QuickBooks Online Advanced, Self-Employed, Commerce (for…

Doubt & mispricing

The market doubts it (score 0.99): trading cheap versus its own multi-year range; down 66% from its 1-year high, below its 200-day line.

Recommended next step

RESEARCH THE CAUSE FIRST

It's both cheap vs its own 5-yr range AND down hard — find out WHY. Read the latest 10-K/10-Q on SEC EDGAR (sec.gov/edgar) and the most recent earnings-call transcript; separate a temporary stumble from a structural problem before treating the discount as opportunity.

Recent news

10. TTD The Trade Desk, Inc.

DOUBT EARNED

Advertising Agencies · adj close 19.27 (div-adj)

Quality 91.4% pctile
Market doubt 0.99 / 1.00

News read — the doubt looks earned: Q2 revenue guidance miss: $750M vs. $770M analyst consensus. Hard negative catalyst.. Cuts the opportunity score to 0.77 (from 0.91).

Business quality fingerprint

Returns
ROIC13.4%
ROE17.8%
Gross profitability37.0%
Margins
Gross margin78.6%
Operating margin20.3%
FCF margin27.5% (FCF+)
Growth (3-yr)
Revenue CAGR22.4%
EPS CAGR102.2%
Balance sheet
Net debt / EBITDA-0.29
Share count (5-yr)-3.2%
Quality score0.80 · 91.4% pctile

What it does

The Trade Desk, Inc. is a global technology company that provides a self-service, cloud-based platform. This platform enables advertising buyers to efficiently create, manage, and optimize data-driven digital ad campaigns across diverse formats and channels, including display, video, audio, native, and social media, reaching audiences on computers, mobile devices, and connected TVs. In addition to the platform, the company offers various data and value-added services.

Doubt & mispricing

The market doubts it (score 0.99): trading cheap versus its own multi-year range; down 79% from its 1-year high, below its 200-day line.

Recommended next step

RECONSIDER — DOUBT MAY BE EARNED

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -78.5% (skim recent headlines + the last earnings call).

Recent news points to realized deterioration, not just sentiment — the cheapness may be a value trap. Confirm the cause before acting (base read would say ‘Buy Candidate’).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

How to read this report

improving   deteriorating   flat — direction over the 3-year window

Verdict labels

  • News constructive a real positive catalyst — score lifted
  • Doubt = sentiment the drop looks like noise, not damage — score kept or lifted
  • Debated a real but unresolved question — score about unchanged
  • Doubt earned realized deterioration — score cut; possible value trap
  • Opportunity high quality + high doubt (no news verdict yet)

Key terms

  • Quality %ile how the business ranks on durable quality vs the universe (higher is better)
  • Doubt score how much the market doubts it — cheap vs its own history plus beaten-down on price (0–1)
  • Opportunity high on both quality and doubt — the zone worth investigating
  • Recommended next step a research action for your own judgment — not investment advice
Not investment advice. Transformation Atlas — Research-Based Intelligence. Point-in-time research evidence for human judgment only; not investment advice and not a recommendation to buy or sell any security. Verify each setup independently before acting.